ADRB3 and neuroblastoma: In a recent paper, the specific β3-AR antagonism has been useful in demonstrating the crucial role of β3-AR also in neuroblastoma: the treatment manages to decrease the proliferation rate of neuroblastoma cells and simultaneously increases neuronal differentiation.